InMed Pharmaceuticals Overview

Life ScienceCompany

Where is InMed Pharmaceuticals headquartered?

InMed Pharmaceuticals is headquartered in Vancouver, British Columbia.

What is InMed Pharmaceuticals’ revenue?

InMed Pharmaceuticals disclosed revenue of 5M USD for 2024 and 4M USD for 2023.

How many employees does InMed Pharmaceuticals have?

InMed Pharmaceuticals has 13 employees.

What sector is InMed Pharmaceuticals in?

InMed Pharmaceuticals is a life science company.

When was InMed Pharmaceuticals founded?

InMed Pharmaceuticals was founded in 1981.

InMed Pharmaceuticals

InMed Pharmaceuticals, Inc.

815 West Hastings Street, Suite 310,
Vancouver, British Columbia V6C 1B4
Canada,
(604) 669-7207
www.inmedpharma.com

InMed Pharmaceuticals is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (“CBN”), and is developing IntegraSyn™ to produce pharmaceutical-grade cannabinoids. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs. InMed Pharmaceuticals was formed in 1981 and is based in Vancouver, British Columbia.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.2/yr) # - 1 - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.